PACS Group (NYSE:PACS) Stock Moved Up to Strong-Buy by Wall Street Zen

Wall Street Zen upgraded shares of PACS Group (NYSE:PACS – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday,Wall Street Zen reports.

Several other equities analysts also recently weighed in on the stock. Stephens increased their price target on shares of PACS Group from $60.00 to $64.00 and gave the stock an “overweight” rating in a report on Thursday, November 5th. UBS Group raised their price target on shares of PACS Group from $60.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Oppenheimer upped their price objective on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $65.00 price objective (up from $62.00) on shares of PACS Group in a report on Thursday, November 5th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $62.50.

Check Out Our Latest Report on PACS

PACS Group Stock Up 1.4%

PACS Group stock opened at $43.63 on Friday. The business’s 50-day simple moving average is $45.45 and its two-hundred day simple moving average is $40.65. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.80 and a current ratio of 0.80. The company has a market cap of $6.93 billion, a PE ratio of 24.65, a PEG ratio of 1.42 and a beta of -0.14. PACS Group has a fifty-two week low of $24.61 and a fifty-two week high of $51.68.

PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Equities analysts anticipate that PACS Group will post 2.05 EPS for the current year.

Insider Activity

In related news, CEO Jason Murray sold 167,434 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the sale, the chief executive officer directly owned 53,954,101 shares of the company’s stock, valued at $2,710,654,034.24. This trade represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of PACS Group stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $43.13, for a total value of $1,725,200.00. Following the transaction, the chief operating officer owned 2,496,320 shares of the company’s stock, valued at approximately $107,666,281.60. This represents a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,395,000 shares of company stock valued at $64,793,252 in the last quarter. 70.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On PACS Group

Hedge funds have recently bought and sold shares of the stock. Zacks Investment Management lifted its stake in shares of PACS Group by 11.3% in the 3rd quarter. Zacks Investment Management now owns 40,754 shares of the company’s stock valued at $1,693,000 after purchasing an additional 4,123 shares during the period. Aquatic Capital Management LLC purchased a new stake in PACS Group during the third quarter worth $723,000. Cetera Investment Advisers boosted its holdings in PACS Group by 57.1% during the third quarter. Cetera Investment Advisers now owns 18,201 shares of the company’s stock worth $756,000 after buying an additional 6,619 shares in the last quarter. Caxton Associates LLP acquired a new stake in PACS Group during the third quarter valued at $289,000. Finally, Bleakley Financial Group LLC grew its position in PACS Group by 46.7% during the third quarter. Bleakley Financial Group LLC now owns 32,604 shares of the company’s stock valued at $1,355,000 after buying an additional 10,385 shares during the period.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

Further Reading

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.